【レポートの概要（一部）】
1. Report Overview
1.1 Overview of the World Market Clinical Trial Supply and Logistics
1.2 Why You Should Read This Report
1.3 How This Report Delivers
1.4 Main Questions Answered by this Analysis
1.5 Who Is This Study For?
1.6 Methods of Research and Analysis
1.7 Frequently Asked Questions (FAQs)
1.8 Some Associated Reports
1.9 About Visiongain
2. Defining the Clinical Trial Supply and Logistics Market
2.1 An Introduction to the Clinical Trial Supply and Logistics Market
2.2 Clinical Trials are Becoming Increasingly Complex
2.3 Clinical Trial Globalisation: Access to New Markets and New Patients
2.4 Outsourcing Clinical Trial Supply and Logistics
2.5 What Services Are Most Commonly Outsourced?
2.6 Which Companies Participate in the Clinical Trial Supply and Logistics Market?
2.7 Clinical Trial Supply and Logistics: Trends and Future Outlook
3. Clinical Trial Supply and Logistics: World Market Outlook and Forecasting 2015-2025
3.1 The World Clinical Trial Supply and Logistics Market 2013
3.1.1 Which Were the Leading Market Sectors in 2013?
3.2 The World Clinical Trial Supply and Logistics Market Forecast 2015-2025
3.2.1 What Will Drive Market Growth to 2025?
3.2.2 Clinical Trial Supply and Logistics: Market Restraints 2015-2025
3.3 Clinical Trial Manufacturing Submarket 2015-2025
3.3.1 Outlook and Forecast for the Clinical Trial Manufacturing Submarket 2015-2025
3.3.2 Complex Manufacturing and Packaging to Drive Growth 2015-2025
3.3.3 Clinical Trial Packaging Submarket Forecast 2015-2025
3.4 Clinical Trial Logistics and Distribution Submarket 2015-2025
3.4.1 Clinical Trial Logistics and Distribution Submarket Forecast 2015-2025
3.4.2 Submarket Drivers and Restraints 2015-2025
3.4.3 Clinical Trial Cold Chain Distribution Submarket Forecast 2015-2025
3.5 Clinical Trial Supply Chain Management Submarket 2015-2025
3.5.1 Clinical Trial Supply Chain Management Submarket Forecast 2015-2025
3.5.2 Drivers and Restraints for the Clinical Trial Supply Chain Management Submarket 2015-2025
4. Leading National Markets for Clinical Trial Supply and Logistics 2015-2025
4.1 Defining National Submarkets for Clinical Trial Supply and Logistics
4.2 Leading National Submarkets for Clinical Trial Supply and Logistics 2013
4.2.1 How Will These Leading Submarkets Grow 2015-2025?
4.3 Clinical Trial Supply and Logistics in the US 2015-2025
4.3.1 How Will Demand for Clinical Trial Logistics Grow in the US to 2025?
4.4 Western Europe
4.4.1 Western Europe: Clinical Trial Supply and Logistics Submarket Forecast 2015-2025
4.4.2 The EU5: National Submarket Forecasts 2015-2025
4.5 Japan: A New and Growing Market for Outsourced Logistics
4.5.1 Japanese Clinical Trial Supply and Logistics Submarket Forecast 2015-2025
4.6 Clinical Trial Supply in Emerging National Markets
4.7 The Latin American Clinical Trial Supply and Logistics Market 2015-2025
4.7.1 Challenging Distribution Conditions
4.7.2 Brazilian Clinical Trial Supply and Logistics Submarket Forecast 2015-2025
4.8 Russia and Central and Eastern Europe (CEE)
4.8.1 Outsourcing Will Grow Strongly in Russia
4.8.2 Russian Clinical Trial Supply and Logistics Submarket Forecast 2015-2025
4.9 India: An Emerging Destination for Outsourced Clinical Trials
4.9.1 New Clinical Trial Rules Restrain Growth in 2013
4.9.2 Indian Clinical Trial Supply and Logistics Submarket Forecast 2015-2025
4.10 Clinical Trial Supply and Logistics in China 2015-2025
4.10.1 Foreign Investment in Chinese Clinical Trial Logistics
4.10.2 Strong Growth for Clinical Trial Supply and Logistics in China 2015-2025
5. Clinical Trial Supply and Logistics: Regulatory Outlook 2015-2025
5.1 How do Regulatory Standards Affect Clinical Trial Supply?
5.1.1 Good Practices (GxP) in Clinical Trial Distribution
5.1.1.1 Good Manufacturing Practice (GMP)
5.1.1.2 Good Distribution Practice (GDP)
5.1.2 Import Regulations Complicate International Manufacturing and Trials
5.2 Clinical Trial Supply Regulations in the US 2013
5.2.1 Importing Drugs into the US: A Reinterpretation of the Rules
5.3 Clinical Trial Regulations in the EU 2013
5.3.1 Manufacturing Requirements for Clinical Trial Materials in the EU
5.3.2 The European Commission Releases New GDP Guidelines 2013
5.4 GMP and Importation Regulations for Pharmaceuticals in Japan 2013
5.5 Clinical Trial Supply Chain Regulations in Emerging Markets
5.5.1 China: Tougher Regulations for Pharmaceutical Companies and Service Providers
5.5.1.1 Improving Supply Chain Security in China 2013
5.5.2 India: Drug Manufacturing and Imports for Clinical Trials
5.5.2.1 The CDSCO Drafts New GDP Guidelines 2013
5.5.3 Brazil: Slow Regulatory Approval for Clinical Trials
5.5.4 Recent Updates to Pharmaceutical Regulation in Russia
6. Clinical Trial Supply and Logistics: Industry Trends 2015-2025
6.1 Clinical Trial Supply and Logistics Market: Strengths and Weaknesses 2013
6.2 Clinical Trial Supply and Logistics Market: Opportunities and Threats 2015-2025
6.3 Clinical Trial Supply and Logistics Market: STEP Analysis 2015-2025
6.3.1 Social Factors
6.3.2 How Will Novel Technologies Affect the Market to 2025?
6.3.3 Economic Pressures: Demands for Lower Cost Trials and Logistics
6.3.4 Political Issues
6.4 Securing the Clinical Trial Supply Chain 2015-2025
6.4.1 How Will Technology Improve Supply Chain Security?
6.5 How Will Clinical Trial Globalisation Impact Supply and Logistics?
6.6 Trends in Clinical Trial Manufacturing 2015-2025
6.6.1 The Challenge of Comparator Sourcing for Clinical Trials
6.6.1.1 Comparators Are a Source of Risk for Supply Chain Security
6.6.1.2 Regulators and Payers Will Increasingly Demand Comparative Effectiveness Research
6.6.2 Trends in Packaging for Clinical Trials 2015-2025
6.7 Clinical Trial Supply Chain Management Trends to 2025
6.7.1 Forecasting and Modelling to Ensure Sufficient Supply
6.7.2 IT Systems Improve Clinical Trial Planning: IVRS and IWRS
6.7.3 Home-Based Trial Participation: Opportunities and Challenges for Logistics
6.7.4 How Will Greater Use of Adaptive Clinical Trials Impact Trial Logistics?
6.8 Outsourcing Clinical Trial Supply and Logistics
6.8.1 Managing Multiple Supplier Networks
7. The Rise of Cold Chain Logistics in Clinical Trials 2015-2025
7.1 An Introduction to Cold Chain Supply and Distribution
7.1.1 The Importance of Cold Chain for Clinical Trials
7.1.2 Maintaining the Cold Chain
7.2 The Regulatory Outlook for Cold Chain Logistics
7.2.1 International Air Transport Regulations and Guidance: The Temperature Sensitive Label
7.3 Cold Chain Will Account for an Increasing Proportion of Clinical Trial Logistics 2015-2025
7.3.1 Biologic Drug Development Will Stimulate Demand
7.3.1.1 Emerging Trends in Biological Drug Development
7.3.2 Pharma Cold Chain Logistics in Emerging Markets
7.4 The Role of Technology in Clinical Cold Chain Logistics
7.4.1 Active and Passive Temperature Control
7.4.2 There Are Many Ways to Maintain Temperature in the Cold Chain
7.4.2.1 Developments in Phase Change Materials
7.4.2.2 The Benefits of Liquid Nitrogen for Sample Transportation
7.4.3 Advances in RFID for Temperature Monitoring
7.4.3.1 Will Uptake for RFID Grow Among Biopharma Companies to 2025?
7.4.4 Future Technologies for Cold Chain Supply Management
7.4.4.1 Demand for Reusable Cold Chain Packaging
8. Clinical Trial Supply and Logistics Market: Leading Companies
8.1 Third Party Logistics Providers: Leading Clinical Distributors
8.1.1 World Courier: A Pharmaceutical Supply Specialist
8.1.1.1 Distribution Services for Pharma, CROs and Central Laboratories
8.1.1.2 World Courier Is the Clinical Trial Distribution Market Leader
8.1.1.3 World Courier Opens New Service Depots in Europe and Latin America 2013
8.1.2 DHL: A Global Leader in Supply Chain Logistics
8.1.2.1 Life Sciences: A Fast-Growing Source of Revenue for DHL Supply Chain
8.1.2.2 DHL Adds New Services for Healthcare and Clinical Trial Clients 2013
8.1.3 Marken
8.1.3.1 What Services Does Marken Offer Clinical Trial Sponsors?
8.1.3.2 Marken: Challenging Market Conditions 2009-2013
8.1.3.3 Marken Continues to Expand Worldwide
8.1.3.4 Expertise in Biological Sample Management
8.1.4 Other Leading and Emerging Players in the Market
8.1.4.1 TNT Express
8.1.4.2 FedEx
8.1.4.3 Movianto – a European Healthcare Specialist
8.2 Clinical Trial Manufacturing: Submarket Leaders
8.2.1 Catalent Pharma Solutions
8.2.1.1 Clinical Trial Manufacturing and Supply Services
8.2.1.2 Strong Growth for Clinical Manufacturing Revenue
8.2.1.3 Catalent Increases its Focus on Clinical Trial Manufacturing
8.2.2 Patheon
8.2.2.1 Patheon Is a Leader in Pharmaceutical Development Services
8.2.2.2 Patheon Completed 445 Clinical Projects in 2013
8.2.3 Almac Group: Manufacturing, Packaging and Logistics Services
8.2.3.1 Clinical Trial Supply and Management Solutions
8.2.3.2 Almac Opens New Facilities to Expand its Clinical Trial Expertise
8.3 The Role of CROs in the Clinical Trial Supply and Logistics Market
8.3.1 Parexel International
8.3.1.1 Parexel’s Clinical Trial Supply and Logistics Services
8.3.1.2 Parexel Expands Worldwide
8.4 Other Leading Companies in the Clinical Trial Supply and Logistics Market 2013
8.4.1 Fisher Clinical Services (FCS)
8.4.1.1 FCS Offers Manufacturing, Packaging, Storage and Distribution Services
8.4.1.2 Fisher BioServices: Clinical Logistics for the Cell Therapy Industry
8.4.2 Packaging Coordinators Inc. (PCI)
9. Research Interviews from Our Survey
9.1 Dr Pramod Kabra, General Manager and Managing Director, Fisher Clinical Services, India
9.1.1 Fisher Clinical Services
9.1.2 Trends in the Indian Clinical Research Market
9.1.3 Why India Is an Attractive Site for Drug Development
9.1.4 Challenges in Supply and Logistics in India
9.1.5 Addressing the Risk of Counterfeiting
9.1.6 Optimizing Cold Chain Services
9.1.7 Feasibility of Direct-to-Patient Distribution in India
9.1.8 Overcoming Regulatory Hurdles
9.1.9 Forward-Looking Statement
9.2 Ariette van Strien, Senior VP Commercial Operations, Marken, US
9.2.1 Marken
9.2.2 The Landscape of Emerging Markets
9.2.3 Increasing Trend Towards Direct-to-Patient Distribution
9.2.4 Expansion of Marken’s Network
9.2.5 Major Changes in This Decade
9.3 Partha Chatterjee, Global Head, Clinical Research and Clinical Trial Supplies Management, SIRO Clinpharm
9.3.1 SIRO Clinpharm
9.3.2 Clinical Trial Supply Management
9.3.3 SIRO Clinpharm’s New Office in Hyderabad
9.3.4 Challenges to be Addressed
9.3.5 On SIRO Clinpharm’s Services and Strengths
9.4 Ramesh J. Chougule. Partner and AVP – Management Consulting, LifeScience, Infosys
9.4.1 Infosys
9.4.2 Contribution from the Life Sciences Sector
9.4.3 Penetration of the Global Market
9.4.4 Challenges in Emerging Markets
9.4.5 How Will the Market Change in Five Years?
10. Conclusions of Our Study
10.1 The Clinical Trial Supply and Logistics Market 2013
10.2 Outlook for the Market 2014-2025
10.3 Growing Demand for Clinical Logistics in Emerging Countries
10.4 Technology and Innovation to Drive Outsourcing
【レポート販売概要】
■ タイトル：世界における治験用材料・サンプルの供給・物流サービス市場■ 英文：Clinical Trial Supply And Logistics: World Industry And Market Outlook 2015-2025
■ 発行日：2015年1月
■ 調査会社：visiongain
■ 商品コード：VGAIN501166
■ 調査対象地域：グローバル
- Von Willebrand Disease：グローバル臨床試験レビューH2, 2013Von Willebrand Disease Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Von Willebrand Disease Global Clinical Trials Review, H2, 2013" provides data on the Von Willebrand Disease clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Von Willebrand Disease. It includes an overview of the trial numbers and …
- 時間計測器の世界市場予測（～2022）：振動子、共振器、クロック発生器、クロックバッファ、ジッタアッテネータAccording to MarketsandMarkets’ forecast, the timing devices market is expected to be valued at USD 5.92 Billion by 2022, growing at a CAGR of 7.27% between 2017 and 2022. The growth of this market is fueled by the increasing demand for mobile devices, growing adoption of advanced automotive electronics, and rise in demand for healthcare and medical equipment. The market is further driven by the r …
- 反転授業ソリューションの世界市場2016-2020About Flip Classrooms Flipped learning is a hybrid model that combines aspects of traditional learning and blended learning. This model encourages students to take technology-aided lectures outside of the classroom through videos and simulations. Lessons taken in advance by students allow the classroom time to be allocated for group activities and handling subject related queries, resulting in enh …
- 世界の心調律管理装置開発動向：医療機器パイプライン分析2015Cardiac Rhythm Management Devices - Medical Devices Pipeline Assessment, 2015 Summary GlobalData's Medical Devices sector report, “Cardiac Rhythm Management Devices - Medical Devices Pipeline Assessment, 2015" provides an overview of Cardiac Rhythm Management Devices currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the …
- 在宅医療の世界市場：製品、サービス、ソリューションAbout the Home Healthcare Market Home healthcare refers to a wide range of medical products (include heart rate monitors, blood glucose level indicators, and nebulizers), services, and solutions that provide health monitoring, treatment, and physical support to patients or customers at home. People do not need to visit a hospital or any other healthcare facility to benefit from these offerings; th …
- 月経カップの世界市場2017-2021About Menstrual CupsA menstrual cup is a feminine hygiene product. It is a reusable, bell-shaped device worn inside the vagina during menstruation to collect the menstrual fluid. Unlike a tampon, it retains the natural moisture, which is important for vaginal health. It needs to be emptied every 4-12 hours and can be sterilized and reused. Technavio’s analysts forecast the global menstrual cups ma …
- 世界の風力タービン市場分析：Analyzing the Global Wind Turbine MarketWind generation has been growing at a healthy average globally over the last few years, triggered by the fact that more and more countries are realizing the value of wind energy as a low cost, clean source for electricity. This has helped create major new business opportunities for manufacturing and materials innovation in this sector. Driving the wind industry forward is political action in respo …
- フレキソインキの世界市場予測（～2022年）The flexographic ink market is projected to reach USD 4.16 Billion by 2022, at a CAGR 4.89% from 2017 to 2022. The market is largely driven by the increasing demand for flexographic ink from various end-use applications, such as corrugated cardboards, flexible packaging, folding cartons, and tags & labels. The growth of the flexographic ink market can also be attributed to increased investments by …
- 自立生活支援（AAL）及びスマートホームの世界市場動向・予測（～2020）The smart home market is expected to grow from USD 25.38 Billion in 2015 to USD 56.18 Billion by 2020, at a CAGR of 17.2% between 2015 and 2020. The market for ambient assisted living is estimated to grow from USD 1.20 Billion in 2015 to USD 3.96 Billion by 2020. Assisted living products are useful for people with heart disease, stroke, diabetes, obesity, and arthritis among others and these are c …
- Arkansas Electric Cooperative Corporation：発電所及び企業SWTO分析2015Arkansas Electric Cooperative Corporation - Power Plants and SWOT Analysis, 2015 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executives), and major products and services. Scope - Major Power Plants (as …
- Regurgitation：グローバル臨床試験レビューH1, 2013Regurgitation Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, “Regurgitation Global Clinical Trials Review, H1, 2013" provides data on the Regurgitation clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Regurgitation. It includes an overview of the trial numbers and their recruitment status as per the …
- 世界のレオロジー調整剤市場2015The Global Rheology Modifiers Industry Report 2015 is a professional and in-depth study on the current state of the Rheology Modifiers industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Rheology Modifiers market analysis is provided for the international markets including development trends, competit …
- シェールガス処理装置の世界市場：コンポーネント別（内燃機関、圧縮機・ポンプ、電動機械、熱交換器、測定・制御装置、その他）、地域別予測Global Shale Gas Processing Equipment Market to reach USD 12.97 billion by 2025. Global Shale Gas Processing Equipment Market valued approximately USD 3.19 billion in 2016 is forecasted to grow with a healthy growth rate of more than 16.87% over the forecast period 2018-2025. The major factors speculated to augment the markets are escalating energy requirements, improvements in drilling technology …
- キノコ缶詰の世界市場2019-2023About this market Packaging innovations to drive market growth. Packaging plays a major role in the sales of canned mushrooms, in terms of retaining the flavor, taste, product quality, color, texture, and shelf life. Many major companies are collaborating with packaging manufacturers to develop advanced packaging technology for their products to expand their consumer base. The packaging of any pro …
- Enerjisa Enerji Uretim A.S.：発電所及び企業SWTO分析2015Enerjisa Enerji Uretim A.S. - Power Plants and SWOT Analysis, 2015 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executives), and major products and services. Scope - Major Power Plants (assets) - summar …
